Alfredo Leyva-Toledo

Mexico, MEX, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Overexpression of Fut 2, 4, and 8, and nuclear localization of Fut 4 in ovarian cancer cell lines induced by ascitic fluids from epithelial ovarian cancer patients.

Overexpression of Fut 2, 4, and 8, and nuclear localization of Fut 4 in ovarian cancer cell lines induced by ascitic fluids from epithelial ovarian cancer patients.

Journal: Cell biology international

Published: March 23, 2023

A monoclonal antibody against a Leishmania mexicana COX-like enzymatic activity also recognizes similar proteins in different protozoa of clinical importance.

A monoclonal antibody against a Leishmania mexicana COX-like enzymatic activity also recognizes similar proteins in different protozoa of clinical importance.

Journal: Parasitology research

Published: May 27, 2022

PHD finger protein 20-like protein 1 (PHF20L1) in ovarian cancer: from its overexpression in tissue to its upregulation by the ascites microenvironment.

PHD finger protein 20-like protein 1 (PHF20L1) in ovarian cancer: from its overexpression in tissue to its upregulation by the ascites microenvironment.

Journal: Cancer cell international

Published: March 08, 2021

Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in México.

Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in México.

Journal: Archives of gynecology and obstetrics

Published: March 20, 2020

Validation of the Mexican-Spanish Version of the EORTC QLQ-OV28 Instrument for the Assessment of Quality of Life in Women with Ovarian Cancer.

Validation of the Mexican-Spanish Version of the EORTC QLQ-OV28 Instrument for the Assessment of Quality of Life in Women with Ovarian Cancer.

Journal: Archives of medical research

Published: March 14, 2020

PARP inhibitors in ovarian cancer: evidence for maintenance and treatment strategies.

PARP inhibitors in ovarian cancer: evidence for maintenance and treatment strategies.

Journal: Chinese clinical oncology

Published: February 08, 2020

Experiencia con el uso de olaparib en pacientes con cáncer de ovario.

Experiencia con el uso de olaparib en pacientes con cáncer de ovario.

Journal: Gaceta medica de Mexico

Published: December 03, 2019

Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.

Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.

Journal: Translational oncology

Published: September 12, 2019

Ascites from Ovarian Cancer Induces Novel Fucosylated Proteins.

Ascites from Ovarian Cancer Induces Novel Fucosylated Proteins.

Journal: Cancer microenvironment : official journal of the International Cancer Microenvironment Society

Published: October 09, 2018

Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer.

Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer.

Journal: Proteome science

Published: October 02, 2017

GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer.

GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer.

Journal: Oncotarget

Published: August 13, 2017

The translational blocking of α5 and α6 integrin subunits affects migration and invasion, and increases sensitivity to carboplatin of SKOV-3 ovarian cancer cell line.

The translational blocking of α5 and α6 integrin subunits affects migration and invasion, and increases sensitivity to carboplatin of SKOV-3 ovarian cancer cell line.

Journal: Experimental cell research

Published: October 04, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026